Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19)
- 5 August 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 136 (4) , 823-826
Abstract
Recent evidence supports the use of an early, short course of glucocorticoids in patients with COVID-19 who require mechanical ventilation or oxygen support. As the number of coronavirus disease 2019 (COVID-19) cases continues to increase, the number of pregnant women with the disease is very likely to increase as well. Because pregnant women are at increased risk for hospitalization, intensive care unit admission, and mechanical ventilation support, obstetricians will be facing the dilemma of initiating maternal corticosteroid therapy while weighing its potential adverse effects on the fetus (or neonate if the patient is postpartum and breastfeeding). Our objective is to summarize the current evidence supporting steroid therapy in the management of patients with acute respiratory distress syndrome and COVID-19 and to elaborate on key modifications for the pregnant patient.Keywords
This publication has 21 references indexed in Scilit:
- Antenatal corticosteroids for maturity of term or near term fetuses: systematic review and meta-analysis of randomized controlled trialsBMJ, 2016
- Antenatal Betamethasone for Women at Risk for Late Preterm DeliveryNew England Journal of Medicine, 2016
- Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literatureIntensive Care Medicine, 2015
- Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: A meta-analysis of randomized controlled trialsJournal of Critical Care, 2010
- Methylprednisolone Infusion in Early Severe ARDSChest, 2007
- Metabolism of Synthetic Steroids by the Human PlacentaPlacenta, 2007
- Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome*Critical Care Medicine, 2006
- Hydrocortisone Infusion for Severe Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Methylprednisolone Achieves Greater Concentrations in the Lung Than Prednisolone: A Pharmacokinetic AnalysisAmerican Review of Respiratory Disease, 1991
- Penetration of corticosteroids into the lung: Evidence for a difference between methylprednisolone and prednisoloneJournal of Allergy and Clinical Immunology, 1989